There are four legitimate paths to a GLP-1 medication in the United States. Picking the right one depends mostly on your insurance and your indication.
1. Primary care or specialist
The most boring and most reliable route. Your PCP, endocrinologist, or obesity-medicine specialist can prescribe any FDA-approved GLP-1.
- Best when: you have insurance, want continuity of care, or have complex comorbidities.
- Watch for: prior authorization. Most plans require documented BMI, failed lifestyle attempts, or specific A1c thresholds.
2. Telehealth platforms
Companies like Ro, Sequence (WeightWatchers Clinic), Form Health, Noom Med, and Hims/Hers offer GLP-1 evaluations and prescriptions via video. Most can run insurance or self-pay.
- Best when: you want a faster intake than a months-long waitlist for an obesity specialist.
- Watch for: whether they prescribe brand-name FDA-approved medication or compounded semaglutide/tirzepatide. The latter is much cheaper but riskier — see below.
3. Manufacturer direct programs
- Lilly Direct — self-pay Zepbound vials at reduced cash prices (~$349–$549/month depending on dose).
- NovoCare — savings cards bringing Wegovy/Ozempic to $0–$25 for many commercially insured patients; patient assistance for the uninsured.
These are the most reliable cash-pay options if insurance won’t cover the drug.
4. Compounded GLP-1s — proceed carefully
For most of 2023–2025, FDA shortages of semaglutide and tirzepatide allowed 503A and 503B compounding pharmacies to legally produce alternatives. As of late 2024 / early 2025, both drugs were declared off the shortage list, and the FDA has begun enforcement against most compounded versions.
Today, compounded semaglutide and tirzepatide are largely no longer permitted, though some clinics offer “personalized” compounded variants (with added B12, different salts, etc.) under a narrower regulatory exception. These come with serious caveats:
- No FDA review of potency, sterility, or stability.
- Documented cases of dosing errors leading to hospitalization.
- Variable quality between compounders.
- Unclear legal status that has shifted multiple times.
If you choose this path, use only 503B outsourcing facilities (FDA-registered), verify the pharmacy on the FDA’s registered outsourcing list, and confirm the prescriber holds a valid US license via your state medical board.
What to avoid entirely
- “Research peptides” sold online “not for human use.” These are unregulated, often contaminated, and illegal to inject.
- Overseas pharmacies shipping unlabeled pens.
- Social media sellers offering “discount Ozempic.” Counterfeit pens have caused hospitalizations and at least one death tracked by the FDA.
How much will it cost?
| Scenario | Typical monthly cost |
|---|---|
| Insurance covers (diabetes) | $0–$50 |
| Insurance covers (obesity) | $25–$200 |
| Manufacturer self-pay (Lilly Direct) | $349–$549 |
| Cash-pay retail | $900–$1,400 |
| Compounded (where still legal) | $150–$400 |
A reasonable order of operations
- Check your formulary. Search your insurer’s drug list for the brand name. Compare cash prices on GoodRx and Cost Plus Drugs.
- Talk to your PCP first. If they’re comfortable prescribing, this is the cleanest path. The Obesity Medicine Association maintains a directory of board-certified obesity specialists.
- If insurance won’t cover obesity treatment, look at Lilly Direct (Zepbound) or NovoCare (Wegovy) before telehealth.
- Only consider compounded versions if a board-certified clinician you trust is prescribing through an FDA-registered 503B facility.
Once you have a prescription, our side-effects guide covers what to expect in the first few months, and our drug rankings help you compare options.